TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · IEX Real-Time Price · USD
5.06
-0.27 (-5.07%)
Jul 2, 2024, 4:30 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $137.43 million as of July 2, 2024. Its market cap has increased by 59.80% in one year.
Market Cap
137.43M
Enterprise Value
135.04M
1-Year Change
59.80%
Ranking
Category
Stock Price
$5.06
Market Cap Chart
Since December 18, 2020, TriSalus Life Sciences's market cap has decreased from $259.00M to $137.43M, a decrease of -46.94%. That is a compound annual growth rate of -16.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 144.80M | -34.89% |
| Dec 29, 2023 | 222.40M | -29.04% |
| Dec 30, 2022 | 313.40M | 1.52% |
| Dec 31, 2021 | 308.70M | 17.60% |
| Dec 31, 2020 | 262.50M | 1.35% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 150.41M |
| Stereotaxis | 150.41M |
| Context Therapeutics | 150.37M |
| Vigil Neuroscience | 150.34M |
| TruBridge | 150.07M |
| Atossa Therapeutics | 149.65M |
| Quantum-Si incorporated | 148.91M |
| Caribou Biosciences | 148.12M |